Literature DB >> 27533311

Role of Versican in the Pathogenesis of Peritoneal Endometriosis.

Hirohiko Tani1, Yukiyasu Sato1, Masashi Ueda1, Yumiko Miyazaki1, Koh Suginami1, Akihito Horie1, Ikuo Konishi1, Tamayuki Shinomura1.   

Abstract

CONTEXT: Sampson's theory cannot explain why only some cycling women develop peritoneal endometriosis. Few studies have focused on the pelvic peritoneum, which receives regurgitated endometrial tissues. We hypothesized that molecular alterations in the peritoneum are involved in the development of peritoneal endometriosis and conducted a microarray analysis to compare macroscopically normal peritoneum sampled from women with peritoneal endometriosis (endometriotic peritoneum) and those without (non-endometriotic peritoneum). Versican, a major proteoglycan component of the extracellular matrix, is one of the molecules up-regulated in endometriotic peritoneum.
OBJECTIVE: To investigate the role of versican in peritoneal endometriosis. Design, Patients, and Main Outcome Measure: Endometriotic peritoneum and non-endometriotic peritoneum were subjected to RT-PCR, immunostaining, and Western blotting. The versican V1 isoform was stably transfected into Chinese hamster ovary cells (CHO-V1), and the effects of CHO-V1-derived conditioned medium (V1-CM) on primary human endometrial stromal cells were investigated with attachment, invasion, and proliferation assays. The effects of peritoneal fluid collected from endometriotic women (endometriotic PF) or cytokines/growth factors, which were shown to be elevated in endometriotic PF, on versican expression in a human peritoneal cell line (HMrSV5) were also examined.
RESULTS: Versican V1 expression levels were significantly higher in endometriotic peritoneum. In vitro, V1-CM promoted attachment to the HMrSV5 cell monolayer as well as the Matrigel invasion of endometrial stromal cells. Although versican V1 expression was up-regulated by TGF-β1 in HMrSV5 cells, it remained unchanged in endometriotic PF.
CONCLUSIONS: Our results suggest the involvement of peritoneal versican in the development of peritoneal endometriosis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27533311     DOI: 10.1210/jc.2016-2391

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Effects of Alanyl-Glutamine Treatment on the Peritoneal Dialysis Effluent Proteome Reveal Pathomechanism-Associated Molecular Signatures.

Authors:  Rebecca Herzog; Michael Boehm; Markus Unterwurzacher; Anja Wagner; Katja Parapatics; Peter Májek; André C Mueller; Anton Lichtenauer; Keiryn L Bennett; Seth L Alper; Andreas Vychytil; Christoph Aufricht; Klaus Kratochwill
Journal:  Mol Cell Proteomics       Date:  2017-12-04       Impact factor: 5.911

2.  Effect of astragaloside IV and the role of nuclear receptor RXRα in human peritoneal mesothelial cells in high glucose‑based peritoneal dialysis fluids.

Authors:  Weiwei Zhu; Xin Zhang; Kun Gao; Xufang Wang
Journal:  Mol Med Rep       Date:  2019-08-22       Impact factor: 2.952

3.  Peritoneal Fluid Cytokines Reveal New Insights of Endometriosis Subphenotypes.

Authors:  Jieliang Zhou; Bernard Su Min Chern; Peter Barton-Smith; Jessie Wai Leng Phoon; Tse Yeun Tan; Veronique Viardot-Foucault; Chee Wai Ku; Heng Hao Tan; Jerry Kok Yen Chan; Yie Hou Lee
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.